GNH USA

Europe — EMA

Levocetirizina Aurovitas Spain

GNH USA supplies Levocetirizina Aurovitas Spain (Levocetirizine), a antihistamine for allergic rhinitis and chronic urticaria. Request a quote for supply.

Levocetirizine Dihydrochloride

Request sourcing

1
Pack/s

What is Levocetirizine Dihydrochloride?

Levocetirizine, the active ingredient in Levocetirizina Aurovitas Spain, is an antihistamine presented as an oral tablet for oral use. It treats allergic rhinitis and chronic urticaria in adults and adolescents, relieving symptoms such as sneezing, nasal congestion, itching and hives.

GNH USA supplies Levocetirizina Aurovitas Spain as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance across EU and global markets, leveraging a robust distribution network to ensure timely delivery.

What is Levocetirizine Dihydrochloride used for?

Levocetirizine acts on the histamine H1 receptor pathway to relieve allergic symptoms.

Allergic rhinitis: reduces nasal congestion, sneezing, itching and watery eyes. Chronic urticaria: alleviates hives and associated itching. Seasonal allergic rhinitis: controls symptoms during pollen exposure. Perennial allergic rhinitis: provides year‑round symptom relief. Allergy‑induced conjunctivitis: diminishes eye irritation and redness.

What are the side effects of Levocetirizine Dihydrochloride?

Levocetirizine may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Drowsiness: mild sedation or sleepiness, especially at treatment initiation. - Dry mouth: reduced salivation causing throat discomfort. - Headache: transient cranial pain.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Angioedema: swelling of face, lips or tongue. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

What precautions apply to Levocetirizine Dihydrochloride?

Before prescribing Levocetirizine, consider the following precautions to ensure safe use. - Renal impairment: dose may need adjustment in patients with reduced kidney function. - Elderly patients: monitor for increased sedation. - Concomitant CNS depressants: avoid additive drowsiness. - Driving and machinery: caution due to possible drowsiness. - Store at ambient temperature below 25°C: keep in original packaging, protect from moisture.

What does Levocetirizine Dihydrochloride interact with?

Levocetirizine can interact with other medicines; be aware of the following.

Major Interactions (Avoid): - Alcohol: may enhance sedative effects. - CNS depressants (e.g., benzodiazepines): increased drowsiness risk.

Moderate Interactions (Monitor Closely): - Theophylline: may increase theophylline plasma levels. - Ritonavir: may raise levocetirizine concentrations. - Anticholinergic agents: additive dry mouth.

Frequently asked questions

What is Levocetirizina Aurovitas Spain used for?+
Levocetirizina Aurovitas Spain contains levocetirizine, an antihistamine indicated for the relief of symptoms associated with allergic rhinitis such as sneezing, nasal congestion and itching, as well as for the management of chronic urticaria (hives) to reduce itching and skin lesions.
How does levocetirizine work?+
Levocetirizine works by selectively blocking peripheral histamine H1 receptors. This prevents histamine released during allergic reactions from binding to its receptors, thereby inhibiting the cascade that leads to vasodilation, increased vascular permeability, and sensory nerve activation, which are responsible for typical allergy symptoms.
What is the usual dose of Levocetirizina Aurovitas Spain?+
The specific dose is determined by the prescribing healthcare professional based on the patient’s age, condition severity and renal function. In clinical practice, an adult dose is often 5 mg once daily, but the exact regimen should always follow the prescriber’s instructions.
Is Levocetirizina Aurovitas Spain safe in pregnancy or breastfeeding?+
Safety data in pregnancy and lactation are limited. Levocetirizine should only be used during pregnancy or while breastfeeding if the potential benefit justifies the potential risk to the fetus or infant. Patients should discuss any concerns with their physician.
How do I order Levocetirizina Aurovitas Spain from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Levocetirizina Aurovitas Spain compare with other antihistamines?+
Levocetirizine is the active enantiomer of cetirizine, offering similar efficacy with a potentially lower incidence of sedation. Compared with first‑generation antihistamines, it provides rapid symptom relief while causing less drowsiness. It is also more selective for H1 receptors than many second‑generation agents, which may translate into a favorable safety profile.
What are the storage and handling requirements for Levocetirizina Aurovitas Spain?+
Store the product at ambient temperature below 25 °C. Keep the tablets in the original blister pack or container, protect them from moisture and direct sunlight, and ensure they are out of reach of children.
How is Levocetirizina Aurovitas Spain administered?+
The medication is taken orally, usually as a tablet, with a glass of water. It can be taken with or without food, and the dose should be swallowed whole; crushing or chewing the tablet is not recommended.
What are the most serious risks associated with Levocetirizina Aurovitas Spain?+
Serious adverse reactions, although rare, include anaphylaxis, angioedema (swelling of the face, lips or tongue) and severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. Immediate medical attention is required if any of these symptoms occur.
Who should not use Levocetirizina Aurovitas Spain?+
Patients with a known hypersensitivity to levocetirizine or any of the tablet’s excipients should avoid the product. Those with severe renal impairment may require dose adjustment or alternative therapy, and individuals taking interacting CNS depressants should be monitored closely for excessive sedation.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Levocetirizine Dihydrochloride
Route
Oral Use
Manufacturer
Aurovitas Spain,s.A.U.
Origin
EU

Related products